Neurocrine Biosciences Inc (NBIX)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -33.598 | -24.105 | 2.332 | 3.22 | 26.79 | 4.707 | 6.958 | 8.886 |
Return on Equity (%) | -38.167 | -41.496 | 4.95 | 6.623 | 46.202 | 7.167 | 10.027 | 12.676 |
Return on Invested Capital (%) | -48.825 | -34.733 | 6.449 | 14.404 | 75.69 | 11.565 | 20.892 | 19.867 |
Operating Margin (%) | -940.6 | -76.113 | 11.606 | 9.961 | 13.338 | 11.222 | 14.845 | 17.842 |
Net Profit Margin (%) | -940.6 | -88.192 | 4.678 | 4.696 | 38.943 | 7.905 | 10.378 | 13.232 |
Book Value Per Share | 3.624 | 4.191 | 5.295 | 6.903 | 12.045 | 14.478 | 17.312 | 22.356 |
Earnings Per Share | -1.624 | -1.605 | 0.233 | 0.401 | 4.356 | 0.944 | 1.601 | 2.541 |
Cash Per Share | 0.958 | 2.869 | 1.561 | 1.217 | 2.001 | 3.591 | 2.724 | 2.556 |
Working Capital Per Share | 3.223 | 5.637 | 7.154 | 2.88 | 8.874 | 7.661 | 9.49 | 9.691 |
Operating Profit Per Share | 0.173 | 1.806 | 4.96 | 8.46 | 11.078 | 11.793 | 15.187 | 18.838 |
EBIT Per Share | -1.624 | -1.605 | 0.241 | 0.504 | 1.141 | 1.068 | 2.217 | 3.38 |
EBITDA Per Share | -1.624 | -1.605 | 0.241 | 0.504 | 1.141 | 1.068 | 2.217 | 3.38 |
Free Cash Flow Per Share | -1.594 | -1.554 | 0.461 | 0.48 | 4.381 | 1.076 | 1.616 | 2.613 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 86.88M | 88.79M | 90.8M | 92.27M | 93.5M | 94.9M | 96.5M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 96.5M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -24.31 | N/A | N/A | N/A | 6.909 | N/A | N/A |
Net Profit Margin (%) | N/A | -18.221 | N/A | N/A | N/A | 8.422 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 14.08B |
Price to Earnings Ratio | 56.4 |
Price to Sales Ratio | 7.46 |
Price to Cash Ratio | 56.08 |
Price to Book Ratio | 6.31 |
Dividend Yield | - |
Shares Outstanding | 101.25M |
Average Volume (1 week) | 1.21M |
Average Volume (1 Month) | 972.91k |
52 Week Change | 6.01% |
52 Week High | 157.9799 |
52 Week Low | 110.95 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.